Welcome to our dedicated page for Sunlink Hlth news (Ticker: SSY), a resource for investors and traders seeking the latest updates and insights on Sunlink Hlth stock.
SunLink Health Systems, Inc. reported corporate-status and transaction developments tied to its completed merger into Regional Health Properties in August 2025. Recurring company news covered material agreements, shareholder voting matters, capital-structure disclosures, governance actions, operating and financial results, and regulatory disclosures. Subsequent public-company developments centered on the NYSE American removal of SunLink common stock and the termination or suspension of Exchange Act reporting obligations.
SunLink Health Systems, Inc. (NYSE American: SSY) reported a loss from continuing operations of $473,000 ($0.07 per share) for Q3 of fiscal 2021, a significant decline from a $46,000 loss in Q3 2020. Total net revenues fell by 22.8% to $9,778,000, primarily due to decreased revenues in its Healthcare and Pharmacy segments linked to COVID-19. For the nine months ending March 31, 2021, net revenues were $30,350,000, down 18.2% year-over-year, leading to an operating loss of $1,117,000. The company has received $5,070,000 in Provider Relief Funds to date.
SunLink Health Systems, Inc. (NYSE American: SSY) announced its Trace Forward Capital Plan, a $2 million initiative to enhance Trace Regional Hospital's facilities and services. Key upgrades include an 8-bed expansion of the Pathways Care Program, modernized patient rooms, a comprehensive replacement of heating, air conditioning, and roofing systems. The plan also includes enhanced diagnostic and IT equipment, expanding telemedicine services and improving security. These enhancements aim to meet the rising demand for senior healthcare in northeast Mississippi and are funded primarily through the hospital's cash reserves.
SunLink Health Systems (SSY) reported earnings from continuing operations of $3,146,000 ($0.46 per share) for Q2 fiscal 2021, up from $203,000 ($0.03 per share) last year.
Net earnings surged to $3,074,000 from a net loss of $42,000. However, consolidated net revenues fell 20.7% to $10,150,000, mainly due to decreased revenues in healthcare and pharmacy segments amid the COVID-19 pandemic. Operating losses were reported at $254,000 compared to profits in the same quarter last year. The company also received $5,008,000 from the Provider Relief Funds under the CARES Act.